BRPI0713441A2 - composiÇÕes e kits que compreendem um componente melatonina e um componente flavanol - Google Patents

composiÇÕes e kits que compreendem um componente melatonina e um componente flavanol Download PDF

Info

Publication number
BRPI0713441A2
BRPI0713441A2 BRPI0713441-0A BRPI0713441A BRPI0713441A2 BR PI0713441 A2 BRPI0713441 A2 BR PI0713441A2 BR PI0713441 A BRPI0713441 A BR PI0713441A BR PI0713441 A2 BRPI0713441 A2 BR PI0713441A2
Authority
BR
Brazil
Prior art keywords
component
kits
compositions
flavanol
melatonin
Prior art date
Application number
BRPI0713441-0A
Other languages
English (en)
Inventor
Patrick Ebel James
Velazquez Jesus
Violet Trejo Amy
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of BRPI0713441A2 publication Critical patent/BRPI0713441A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSIÇÕES E KITS QUE COMPREENDEM UM COMPONENTE MELATONINA E UM COMPONENTE FLAVANOL. A presente invenção refere-se a composições e kits, em que cada composição compreende um componente melatonina, um componente flavanol, ou ambos, e em que cada kit contém um componente melatonina e um componente flavanol. As composições e kits são úteis para a função reparadora do sono e aumento da energia. Adicionalmente, são apresentados, na presente invenção, métodos para uso das composições e kits.
BRPI0713441-0A 2006-06-23 2007-06-22 composiÇÕes e kits que compreendem um componente melatonina e um componente flavanol BRPI0713441A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81607506P 2006-06-23 2006-06-23
US60/816,075 2006-06-23
PCT/IB2007/052439 WO2007148309A2 (en) 2006-06-23 2007-06-22 Compositions and kits comprising a melatonin component and a flavanol component

Publications (1)

Publication Number Publication Date
BRPI0713441A2 true BRPI0713441A2 (pt) 2012-03-06

Family

ID=38740552

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713441-0A BRPI0713441A2 (pt) 2006-06-23 2007-06-22 composiÇÕes e kits que compreendem um componente melatonina e um componente flavanol

Country Status (9)

Country Link
US (2) US20070298133A1 (pt)
EP (1) EP2034988A2 (pt)
JP (1) JP2009539969A (pt)
CN (1) CN101460162A (pt)
AU (1) AU2007262361A1 (pt)
BR (1) BRPI0713441A2 (pt)
CA (1) CA2654464A1 (pt)
MX (1) MX2008016268A (pt)
WO (1) WO2007148309A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150065449A1 (en) * 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
EP2570126B1 (en) * 2011-09-16 2014-03-26 Darius Rassoulian Use of melatonin for treating acute alcohol intoxication
CN104784172B (zh) * 2015-03-30 2017-12-12 安徽农业大学 一种含有褪黑素和儿茶素的组合物及其应用
TWI670059B (zh) * 2017-11-22 2019-09-01 大江生醫股份有限公司 沒食子兒茶素之應用
US11419849B1 (en) * 2019-02-06 2022-08-23 Kitt Bio, Inc. Methods and products for adverse effects of air travel, jet lag, or a change to a sleep wake timing cycle
TW202223918A (zh) * 2020-11-04 2022-06-16 英國商閉環醫藥有限公司 治療支持

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
CN1253773A (zh) * 1999-11-01 2000-05-24 潘璠 褪黑素美白护肤化妆品
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
ITMI20030036A1 (it) * 2003-01-13 2004-07-14 Hunza Di Pistolesi Elvira & C S A S Preparazioni farmacologiche o dietetiche costituite da
US20060286181A1 (en) * 2005-06-17 2006-12-21 Gardiner Paul T Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism
US20070086972A1 (en) * 2005-09-12 2007-04-19 Jacob Birnbaum Hair growth compositions and methods for treating hair loss or related conditions

Also Published As

Publication number Publication date
WO2007148309A2 (en) 2007-12-27
AU2007262361A1 (en) 2007-12-27
US20080262072A1 (en) 2008-10-23
CN101460162A (zh) 2009-06-17
WO2007148309A3 (en) 2008-10-23
JP2009539969A (ja) 2009-11-19
CA2654464A1 (en) 2007-12-27
EP2034988A2 (en) 2009-03-18
US20070298133A1 (en) 2007-12-27
MX2008016268A (es) 2009-03-09

Similar Documents

Publication Publication Date Title
ECSP10010095A (es) 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa
BRPI0907663A8 (pt) composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0607279A2 (pt) composição compatìvel com fertilizante
DOP2011000084A (es) Uso de ditiina-tetracarboximidas para combatir hongos fitopatogenos
MX2008006580A (es) Composicion de cereal que comprende edulcorante de alta potencia
MX2010003452A (es) Composiciones de tratamiento para el cabello.
BRPI0719497A2 (pt) "composição, processo de preparação de uma composição, usos de uma composição e uso coméstico de uma composição"
BRPI0517616A (pt) composição implantável, métodos para aumentar tecido mole em um indivìduo, e para preparar uma composição de colágeno implantável, e kit
CR20110553A (es) Terapia complementaria contra el cáncer
NO20081618L (no) Anvendelse av proteiner som en antiskumdannende komponent i drivstoff
BRPI0917728A2 (pt) composição, uso da composição, e, método de prevenção da formação de espuma em uma composição
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
BRPI0918487A2 (pt) processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
BRPI0821240A2 (pt) formas mutantes de estreptolisina o
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
HN2006037713A (es) Compuestos utiles en terapia
BRPI0617294B8 (pt) composição farmacêutica em gel hidroalcóolico e uso de testosterona
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
AR054937A1 (es) Goma de mascar biodegradable
BRPI0606358A2 (pt) uso de pelo menos um aminoditiol, processo e kit para a deformação permanente dos cabelos e aminotióis
WO2007148309A3 (en) Compositions and kits comprising a melatonin component and a flavanol component
ECSP077129A (pt)
BRPI0906653A2 (pt) Uso de uma composição que contém galacto-oligossacarídeo, fruto-oligossacarídeo e hidrolisado de pectina.
BRPI0905885A2 (pt) "processo de preparação de uma composição que contém polímero, composição e uso da composição"

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 5A ANUIDADE.